Trials / Completed
CompletedNCT00805155
Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions
Bioequivalence of Three Mometasone Furoate 0.1% Topical Lotions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Mometasone Furoate 0.1% Topical Lotions in healthy, female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mometasone Furoate 0.1% Topical Lotion-Reference Product | Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response. |
| DRUG | Mometasone Furoate 0.1% Topical Lotion-Test product 1 | Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response. |
| DRUG | Mometasone Furoate 0.1% Topical Lotion-Test Product 2 | Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response. |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2008-12-09
- Last updated
- 2021-10-15
Source: ClinicalTrials.gov record NCT00805155. Inclusion in this directory is not an endorsement.